TRCT
WGBS

Tower Research Capital (TRC)’s WaferGen Bio-systems, Inc. WGBS Stock Holding History

Tower Research Capital (TRC)’s Portfolio WGBS Stock Details WGBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-340
Closed -$8K – 5461
2015
Q1 		$8K Buy
+340
New +$6.75K ﹤0.01% 3006
2014
Q4 		– Sell
-40
Closed -$1K – 5198
2014
Q3 		$1K Buy
+40
New +$891 ﹤0.01% 4260

Other funds holding WGBS

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $679M AUM 50.89% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tower Research Capital (TRC)'s WGBS Position: Q2 2015 in Review

Tower Research Capital (TRC) sold out of WaferGen Bio-systems, Inc. (WGBS) in Q2 2015, closing a stake of 340 shares — an estimated $8K sold.

Tower Research Capital (TRC) first reported a position in WGBS in Q3 2014 and held it in 2 quarters. The position peaked at $8K in Q1 2015. 10 funds tracked by Wall St. Rank hold WGBS as of Q2 2015.

  • Tower Research Capital (TRC) reported no remaining WaferGen Bio-systems, Inc. position as of Q2 2015 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 340 WaferGen Bio-systems, Inc. shares in Q2 2015, an estimated $8K.
  • Tower Research Capital (TRC) first reported a position in WaferGen Bio-systems, Inc. in Q3 2014 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s WaferGen Bio-systems, Inc. position peaked at $8K in Q1 2015.
  • 10 funds tracked by Wall St. Rank held WaferGen Bio-systems, Inc. as of Q2 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.